Amag Pharmaceuticals Inc.

Iron Deficiency Anemia

Clinical research is centered on iron deficiency anemia, with attention to restoring iron status in affected patients and addressing the conditions associated with low iron stores.

  • Iron replacement therapy
  • Iron sucrose comparison
  • Ferumoxytol

Interest extends to patients who are at risk of developing iron deficiency anemia, reflecting a focus on treatment options for both established and emerging iron deficiency.

Pediatric Nephrology

Another key area is pediatric chronic kidney disease, particularly where impaired kidney function is linked with iron deficiency anemia and related hematologic needs.

  • Children with chronic kidney disease
  • Pediatric anemia management
  • Renal-associated iron deficiency

The research landscape includes pediatric subjects with kidney disease who require careful management of iron deficiency and anemia-related complications.

Hematology and Iron Therapy

The sponsor’s clinical interest includes hematology with a strong emphasis on therapies designed to correct iron deficiency and support red blood cell health.

  • Parenteral iron therapy
  • Safety and efficacy evaluation
  • Iron repletion

This area reflects work focused on therapeutic options for patients needing medically supervised iron replacement.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children

    Recruiting

    1 1 1 1
    Investigated drugs:
    Lithuania Poland
  • Comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children with chronic kidney disease

    Recruiting

    1 1 1 1
    Investigated drugs:
    Hungary Lithuania Poland